PegIntron was the first long-acting interferon approved by the EU and US FDA in 2000 and 2001 for the treatment of chronic hepatitis C. It has not been approved for the treatment of chronic hepatitis B. It was approved for the treatment of chronic hepatitis C in China in May 2004, and was approved for the treatment of chronic hepatitis B in China in March 2007.

When choosing PegIntron Interferon, pet owners should fully understand the drug’s indications, usage and dosage, and possible side effects. Make sure medicines work safely and effectively. At the same time, you should also choose products with high cost performance based on your own financial affordability.